At the same time, a follow-up study on the risk of developing non-alcoholic liver dysfunction using serum alanine aminotransferase (ALT) concentration, a marker of liver damage, also revealed that the risk of developing NAFLD was significantly reduced in the high serum provitamin A concentration group [23]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.